Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jiao-En Wu

43PUBLICATIONS

52CO-AUTHORS

Cancer geneticsMolecular targetsPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Feb 10, 2026

Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. <i>Cancers</i> 2021, <i>13</i>, 3876.

Chiao-En Wu, Ahmed Khairallah Mahdi, Chen-Yang Huang

|Jan 10, 2026

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring <i>ROS1</i> Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy.

Yan-Jei Tang, Rung-Hsuan Chen, Yung-Shin Lu

|Nov 22, 2025

PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target.

Chiao-Ping Chen, Tsai-Hsien Hung, Yenlin Huang

|Nov 20, 2025

Clinicopathological Features and Immunochemical Staining of Inflammatory Myofibroblastic Tumor: A Retrospective Study of 48 Cases.

Qi-An Wang, Ren-Chin Wu, Chao-Wei Lee

|Oct 27, 2025

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan.

Wei-Ming Huang, Chen-Han Chueh, Chien-Yu Tseng

|Jul 08, 2025

Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study.

I-Lin Tsai, Chien-Yu Lin, Po-Lan Su

Pageof 8

Frequent Collaborators

6 joint publications

Yi-Ru Pan

5 joint publications

Jen-Shi Chen

5 joint publications

Wen-Kuan Huang

5 joint publications

Chun-Nan Yeh

3 joint publications

Shang-Yu Wang

3 joint publications

Cheng-Ta Yang

3 joint publications

Ching-Fu Chang

2 joint publications

Ming-Huang Chen

2 joint publications

John Lunec

2 joint publications

Chen-Yang Huang

Frequent Collaborators

6 joint publications

Yi-Ru Pan

5 joint publications

Jen-Shi Chen

5 joint publications

Wen-Kuan Huang

5 joint publications

Chun-Nan Yeh

Top Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on : Aug 04, 2019

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on : Aug 04, 2019

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos